Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides
Open Access
- 24 February 2003
- journal article
- review article
- Published by Hindawi Limited in Human Mutation
- Vol. 21 (3) , 192-200
- https://doi.org/10.1002/humu.10189
Abstract
A detailed analysis of p53 (TP53) mutations involving the 42 CpG dinucleotides was performed to gain greater insight into the mutational mechanism leading to specific selection of these mutations. Although the majority of these CpG dinucleotides have been found to be mutated in cancer cells, the heterogeneous frequency of mutational events suggests that some mutations are not true mutations, but neutral changes that have been co‐selected during oncogenic transformation. Among the 1,400 variants found in the 15,000 mutations of the p53 database, 5% have only been described once, indicating that either the mutational event is rare, or the mutation phenotype is very mild, or both. Overall, these data indicate that great caution is required when analyzing the significance of p53 mutations. Hum Mutat 21:192–200, 2003.Keywords
Funding Information
- Fondation de France
This publication has 38 references indexed in Scilit:
- Focus on the p53 gene and cancer: Advances inTP53 mutation researchHuman Mutation, 2003
- Splice mutations in the p53 gene: case report and review of the literatureHuman Mutation, 2002
- Time for a Unified System of Mutation Description and Reporting: A Review of Locus-Specific Mutation DatabasesGenome Research, 2002
- Mutation detection 2001: Novel technologies, developments and applications for analysis of the human genomeHuman Mutation, 2002
- The p53 and Mdm2 families in cancerCurrent Opinion in Genetics & Development, 2002
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001
- Characterization of germline TP53 splicing mutations and their genetic and functional analysisOncogene, 2001
- Involvement of 5-methylcytosine in sunlight-induced mutagenesis 1 1Edited by J. KarnJournal of Molecular Biology, 1999
- Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic testsHuman Molecular Genetics, 1994
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992